Unravelling the Riddle of Gastroesophageal Reflux Disease, Obesity, and Barrett's Esophagus

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 13, 2015, Pages 2273-2275

  Kendall, Bradley J ^a,b,c   Thrift, Aaron P ^d  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; LEPTIN; ADIPOCYTOKINE;

ABDOMINAL FAT; ABDOMINAL OBESITY; BARRETT ESOPHAGUS; BODY FAT DISTRIBUTION; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; DEVELOPED COUNTRY; DISEASE ASSOCIATION; EDITORIAL; ESOPHAGEAL ADENOCARCINOMA; ETHNICITY; GASTROESOPHAGEAL REFLUX; HIGH RISK PATIENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; METABOLIC SYNDROME X; METASTASIS POTENTIAL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESSURE GRADIENT; PREVALENCE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; STOMACH PRESSURE; WAIST HIP RATIO; BLOOD; CHEMISTRY; COMPLICATION; FEMALE; MALE; PATHOLOGY; SERUM;

ADIPOKINES; ADIPONECTIN; BARRETT ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; INSULIN; LEPTIN; MALE; SERUM;

EID: 84947417708     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.08.024     Document Type: Editorial

References (23)

1. Thrift A.P., Whiteman D.C. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol 2012, 23:3155-3162.
2. Chandrasoma P., Wickramasinghe K., Ma Y., et al. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?. Dis Esophagus 2007, 20:36-41.
3. Cook M.B., Wild C.P., Forman D. A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol 2005, 162:1050-1061.
4. Cook M.B., Wood S.N., Cash B.D., et al. Association between circulating levels of sex steroid hormones and Barrett's esophagus in men: a case-control analysis. Clin Gastroenterol Hepatol 2015, 13:673-682.
5. Anderson L.A., Watson R.G., Murphy S.J., et al. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol 2007, 13:1585-1594.
6. Kennedy T., Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000, 14:1589-1594.
7. Whiteman D.C., Sadeghi S., Pandeya N., et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008, 57:173-180.
8. Wang Y., Beydoun M.A. The obesity epidemic in the United States: gender, age, socioeconomic, racial/ethnic, and geographic characteristics-a systematic review and meta-regression analysis. Epidemiol Rev 2007, 29:6-28.
9. Adams R.J., Appleton S., Wilson D.H., et al. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care 2005, 28:2777-2779.
10. Yang X., Smith U. Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer?. Diabetologia 2007, 50:1127-1139.
11. Kendall B.J., Wilson L.F., Olsen C.M., et al. Cancers in Australia in 2010 attributable to overweight and obesity. Aust N Z J Public Health 2015, 39:452-457.
12. Kubo A., Corley D.A. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:872-878.
13. Singh S., Sharma A.N., Murad M.H., et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013, 11:1399-1412.
14. Thrift A.P., Shaheen N.J., Gammon M.D., et al. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. J Natl Cancer Inst 2014, 106.
15. El-Serag H.B., Ergun G.A., Pandolfino J., et al. Obesity increases oesophageal acid exposure. Gut 2007, 56:749-755.
16. Pandolfino J.E., El-Serag H.B., Zhang Q., et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 2006, 130:639-649.
17. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
18. Daly J.M., Fry W.A., Little A.G., et al. Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg 2000, 190:562-572.
19. Almers L.M., Graham J.E., Havel P.J., et al. Adiponectin may modify the risk of Barrett's esophagus in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2015, 13:2256-2264.
20. Greer K.B., Falk G.W., Bednarchik B., et al. Associations of serum adiponectin and leptin with Barrett's esophagus. Clin Gastroenterol Hepatol 2015, 13:2265-2272.
21. Chandar A.K., Devanna S., Lu C., et al. Association of serum levels of adipokines and insulin with risk of Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015, 13:2241-2255.
22. Thrift A.P., Risch H.A., Onstad L., et al. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization. Clin Gastroenterol Hepatol 2014, 12:1667-1676.
23. Duggan C., Onstad L., Hardikar S., et al. Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2013, 11:934-943.